A role of FDG-PET/CT for response evaluation in metastatic breast cancer? Hildebrandt MG, Naghavi-Behzad M, Vogsen M. Semin Nucl Med 2022 May 4. pii: S0001-2998(22)00029.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Hildebrandt MG, Naghavi-Behzad M, Vogsen M. A role of FDG-PET/CT for response evaluation in metastatic breast cancer? Semin Nucl Med 2022 May 4. pii: S0001-2998(22)00029.
PMID: 35525631